Systemic Immune-Inflammation Index (SII) Predicts Increased Severity in Psoriasis and Psoriatic Arthritis.

Systemic immune‐inflammation index, neutrophil‐to‐lymphocyte ratio, platelet‐to‐lymphocyte ratio can predict clinical outcomes in patients with metastatic non‐small‐cell lung cancer treated with nivolumab

Jingjing Liu, Shuang Li, Shuang Zhang et al. · Journal of Clinical Laboratory Analysis · 2019 · 357 citations · Full text

Current Developments in the Immunology of Psoriasis.

Franziska Grän, Andreas Kerstan, Edgar Serfling et al. · PubMed · 2020 · 200 citations · Full text

Inflammation, Cytokine, Current Developments +12

Systemic immune-inflammation index (SII) is a useful prognostic indicator for patients with squamous cell carcinoma of the esophagus

Ji‐Feng Feng, Sheng Chen, Xun Yang · Medicine · 2017 · 112 citations · Full text

Pre‐treatment systemic immune‐inflammation index is a useful prognostic indicator in patients with breast cancer undergoing neoadjuvant chemotherapy

Li Chen, Xiangyi Kong, Zhongzhao Wang et al. · Journal of Cellular and Molecular Medicine · 2020 · 88 citations · Full text

Predictive value of lymphocyte-to-monocyte ratio (LMR) and neutrophil-to-lymphocyte ratio (NLR) in patients with oesophageal cancer undergoing concurrent chemoradiotherapy

Kejie Li, Xiao-Fang Xia, Meng Su et al. · BMC Cancer · 2019 · 76 citations · Full text